表紙
市場調查報告書
商品編碼
1017138

羊膜的全球市場:2021年∼2025年

Global Amniotic Membrane Market 2021-2025

出版日期: | 出版商: TechNavio (Infiniti Research Ltd.) | 英文 120 Pages | 訂單完成後即時交付

價格
  • 全貌
  • 簡介
  • 目錄
簡介

全球羊膜的市場規模在2021年∼2025年間,預測將成長到9億5486萬美元,在預測期間中預計將以12%的年複合成長率增長。

該市場成長的主要因素有眼科手術上羊膜移植的廣泛使用,創傷修復及重組的羊膜高需求。

本報告涵括羊膜的全球市場的整體分析,提供市場規模與預測,趨勢,成長要素,課題,及約25供應商的分析。

目錄

摘要整理

市場形勢

  • 市場生態系統
  • 價值鏈分析

市場規模

  • 市場定義
  • 市場區隔分析
  • 2020年的市場規模
  • 市場預測:從2020年∼2025年的預測

波特的五力分析

  • 五力彙整
  • 買方議價能力
  • 供給企業談判力
  • 新加入廠商業者的威脅
  • 替代品的威脅
  • 競爭的威脅
  • 市場情況

市場區隔:各類型

  • 市場區隔
  • 各類型比較
  • 凍結保存羊膜:市場規模與預測(2020年∼2025年)
  • 乾燥羊膜:市場規模與預測(2020年∼2025年)
  • 各類型的市場機會

客戶形勢

各地區形勢

  • 各地區市場區隔
  • 各地區比較
  • 北美:市場規模與預測(2020年∼2025年)
  • 歐洲:市場規模與預測(2020年∼2025年)
  • 亞洲:市場規模與預測(2020年∼2025年)
  • 其他地區:市場規模與預測(2020年∼2025年)
  • 主要國家
  • 地區的市場機會
  • 市場推動因素
  • 市場課題
  • 市場趨勢

業者情勢

  • 概要
  • 業者情勢
  • 創造性破壞狀況

供應商分析

  • 交易廠商
  • 供應商的市場定位
  • Celularity Inc.
  • Human Regenerative Technologies LLC
  • Integra LifeSciences Holdings Corp.
  • Katena Products Inc.
  • MiMedx Group Inc.
  • NuVision Biotherapies Ltd.
  • Orthofix Medical Inc.
  • Stryker Corp.
  • Surgenex LLC
  • TissueTech Inc.

附錄

目錄
Product Code: IRTNTR40730

Technavio has been monitoring the amniotic membrane market and it is poised to grow by $ 954.86 million during 2021-2025, progressing at a CAGR of about 12% during the forecast period. Our report on the amniotic membrane market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current global market scenario, latest trends and drivers, and the overall market environment. The market is driven by the extensive use of amniotic membrane transplantation in ophthalmic surgeries and the high demand for amniotic membrane in wound repair and reconstruction. In addition, the extensive use of amniotic membrane transplantation in ophthalmic surgeries is anticipated to boost the growth of the market as well.

The amniotic membrane market analysis includes the type segment and geographic landscape.

Technavio's amniotic membrane market is segmented as below:

By Type

  • Cryopreserved amniotic membrane
  • Dehydrated amniotic membrane

By Geography

  • North America
  • Europe
  • Asia
  • ROW

This study identifies the rising demand for biocompatible scaffolds as one of the prime reasons driving the amniotic membrane market growth during the next few years.

Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters. Our report on amniotic membrane market covers the following areas:

  • Amniotic membrane market sizing
  • Amniotic membrane market forecast
  • Amniotic membrane market industry analysis

Technavio's robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading amniotic membrane market vendors that include Celularity Inc., Stryker Corp., Surgenex LLC, Katena Products Inc., MiMedx Group Inc., NuVision Biotherapies Ltd., Orthofix Medical Inc.TissueTech Inc., Integra LifeSciences Holdings Corp., and Human Regenerative Technologies LLC. Also, the amniotic membrane market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. Technavio's market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.

Table of Contents

  • Executive Summary
    • Market Overview
  • Market Landscape
    • Market ecosystem
    • Value chain analysis
  • Market Sizing
    • Market definition
    • Market segment analysis
    • Market size 2020
    • Market outlook: Forecast for 2020 - 2025
  • Five Forces Analysis
    • Five forces summary
    • Bargaining power of buyers
    • Bargaining power of suppliers
    • Threat of new entrants
    • Threat of substitutes
    • Threat of rivalry
    • Market condition
  • Market Segmentation by Type
    • Market segments
    • Comparison by Type
    • Cryopreserved amniotic membrane - Market size and forecast 2020-2025
    • Dehydrated amniotic membrane - Market size and forecast 2020-2025
    • Market opportunity by Type
  • Customer landscape
  • Geographic Landscape
    • Geographic segmentation
    • Geographic comparison
    • North America - Market size and forecast 2020-2025
    • Europe - Market size and forecast 2020-2025
    • Asia - Market size and forecast 2020-2025
    • ROW - Market size and forecast 2020-2025
    • Key leading countries
    • Market opportunity by geography
    • Market drivers
    • Market challenges
    • Market trends
  • Vendor Landscape
    • Overview
    • Vendor landscape
    • Landscape disruption
  • Vendor Analysis
    • Vendors covered
    • Market positioning of vendors
    • Celularity Inc.
    • Human Regenerative Technologies LLC
    • Integra LifeSciences Holdings Corp.
    • Katena Products Inc.
    • MiMedx Group Inc.
    • NuVision Biotherapies Ltd.
    • Orthofix Medical Inc.
    • Stryker Corp.
    • Surgenex LLC
    • TissueTech Inc.
  • Appendix
    • Scope of the report
    • Currency conversion rates for US$
    • Research methodology
    • List of abbreviations

Exhibits

  • 1: Key Finding 1
  • 2: Key Finding 2
  • 3: Key Finding 3
  • 4: Key Finding 5
  • 5: Key Finding 6
  • 6: Key Finding 7
  • 7: Key Finding 8
  • 8: Parent market
  • 9: Market characteristics
  • 10: Offerings of vendors included in the market definition
  • 11: Market segments
  • 12: Global - Market size and forecast 2020 - 2025 ($ million)
  • 13: Global market: Year-over-year growth 2020 - 2025 (%)
  • 14: Five forces analysis 2020 & 2025
  • 15: Bargaining power of buyers
  • 16: Bargaining power of suppliers
  • 17: Threat of new entrants
  • 18: Threat of substitutes
  • 19: Threat of rivalry
  • 20: Market condition - Five forces 2020
  • 21: Type - Market share 2020-2025 (%)
  • 22: Comparison by Type
  • 23: Cryopreserved amniotic membrane - Market size and forecast 2020-2025 ($ million)
  • 24: Cryopreserved amniotic membrane - Year-over-year growth 2020-2025 (%)
  • 25: Dehydrated amniotic membrane - Market size and forecast 2020-2025 ($ million)
  • 26: Dehydrated amniotic membrane - Year-over-year growth 2020-2025 (%)
  • 27: Market opportunity by Type
  • 28: Customer landscape
  • 29: Market share by geography 2020-2025 (%)
  • 30: Geographic comparison
  • 31: North America - Market size and forecast 2020-2025 ($ million)
  • 32: North America - Year-over-year growth 2020-2025 (%)
  • 33: Europe - Market size and forecast 2020-2025 ($ million)
  • 34: Europe - Year-over-year growth 2020-2025 (%)
  • 35: Asia - Market size and forecast 2020-2025 ($ million)
  • 36: Asia - Year-over-year growth 2020-2025 (%)
  • 37: ROW - Market size and forecast 2020-2025 ($ million)
  • 38: ROW - Year-over-year growth 2020-2025 (%)
  • 39: Key leading countries
  • 40: Market opportunity by geography ($ million)
  • 41: Impact of drivers and challenges
  • 42: Vendor landscape
  • 43: Landscape disruption
  • 44: Industry risks
  • 45: Vendors covered
  • 46: Market positioning of vendors
  • 47: Celularity Inc. - Overview
  • 48: Celularity Inc. - Product and service
  • 49: Celularity Inc. - Key offerings
  • 50: Celularity Inc. - Key customers
  • 51: Celularity Inc. - Segment focus
  • 52: Human Regenerative Technologies LLC - Overview
  • 53: Human Regenerative Technologies LLC - Product and service
  • 54: Human Regenerative Technologies LLC - Key offerings
  • 55: Human Regenerative Technologies LLC - Key customers
  • 56: Human Regenerative Technologies LLC - Segment focus
  • 57: Integra LifeSciences Holdings Corp. - Overview
  • 58: Integra LifeSciences Holdings Corp. - Business segments
  • 59: Integra LifeSciences Holdings Corp. - Key offerings
  • 60: Integra LifeSciences Holdings Corp. - Key customers
  • 61: Integra LifeSciences Holdings Corp. - Segment focus
  • 62: Katena Products Inc. - Overview
  • 63: Katena Products Inc. - Product and service
  • 64: Katena Products Inc. - Key offerings
  • 65: Katena Products Inc. - Key customers
  • 66: Katena Products Inc. - Segment focus
  • 67: MiMedx Group Inc. - Overview
  • 68: MiMedx Group Inc. - Business segments
  • 69: MiMedx Group Inc. - Key offerings
  • 70: MiMedx Group Inc. - Key customers
  • 71: MiMedx Group Inc. - Segment focus
  • 72: NuVision Biotherapies Ltd. - Overview
  • 73: NuVision Biotherapies Ltd. - Product and service
  • 74: NuVision Biotherapies Ltd. - Key offerings
  • 75: NuVision Biotherapies Ltd. - Key customers
  • 76: NuVision Biotherapies Ltd. - Segment focus
  • 77: Orthofix Medical Inc. - Overview
  • 78: Orthofix Medical Inc. - Business segments
  • 79: Orthofix Medical Inc. - Key offerings
  • 80: Orthofix Medical Inc. - Key customers
  • 81: Orthofix Medical Inc. - Segment focus
  • 82: Stryker Corp. - Overview
  • 83: Stryker Corp. - Business segments
  • 84: Stryker Corp. - Key offerings
  • 85: Stryker Corp. - Key customers
  • 86: Stryker Corp. - Segment focus
  • 87: Surgenex LLC - Overview
  • 88: Surgenex LLC - Product and service
  • 89: Surgenex LLC - Key offerings
  • 90: Surgenex LLC - Key customers
  • 91: Surgenex LLC - Segment focus
  • 92: TissueTech Inc. - Overview
  • 93: TissueTech Inc. - Product and service
  • 94: TissueTech Inc. - Key offerings
  • 95: TissueTech Inc. - Key customers
  • 96: TissueTech Inc. - Segment focus
  • 97: Currency conversion rates for US$
  • 98: Research Methodology
  • 99: Validation techniques employed for market sizing
  • 100: Information sources
  • 101: List of abbreviations